Alaa Abd-Elsayed1, Emily Narel2, Michael Loebertman2. 1. Anesthesiology Department, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA. alaaawny@hotmail.com. 2. Anesthesiology Department, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA.
Abstract
PURPOSE OF REVIEW: We performed this study and associated review to examine whether a one prognostic block is sufficient to proceed with radiofrequency ablation. RECENT FINDINGS: To perform one or two prognostic blocks before performing radiofrequency ablation is a very controversial issue. The practice is inconsistent and insurance companies even do not follow same regulations. We found in our research that majority of patients who receive a successful first prognostic block also receive a successful second prognostic block. We think one prognostic block can be sufficient to move forward with radiofrequency ablation.
PURPOSE OF REVIEW: We performed this study and associated review to examine whether a one prognostic block is sufficient to proceed with radiofrequency ablation. RECENT FINDINGS: To perform one or two prognostic blocks before performing radiofrequency ablation is a very controversial issue. The practice is inconsistent and insurance companies even do not follow same regulations. We found in our research that majority of patients who receive a successful first prognostic block also receive a successful second prognostic block. We think one prognostic block can be sufficient to move forward with radiofrequency ablation.
Entities:
Keywords:
Chronic pain; Knee osteoarthritis; Lumbar facet arthropathy; Lumbar facet dysfunction; One block; Prognostic blocks; Radiofrequency ablation; Two blocks
Authors: Zachary L McCormick; Rajiv Reddy; Marc Korn; David Dayanim; Raafay H Syed; Meghan Bhave; Mikhail Zhukalin; Sarah Choxi; Ali Ebrahimi; Mark C Kendall; Robert J McCarthy; Dost Khan; Geeta Nagpal; Karina Bouffard; David R Walega Journal: Pain Med Date: 2018-08-01 Impact factor: 3.750